IKS Health shares rallied nearly 8% in early trade today after the company announced a major acquisition through its US subsidiary, strengthening its presence in the healthcare technology space.
The stock was trading at ₹1,549.90, up ₹114.60 or 7.98%, following the announcement that its wholly owned US arm has entered into a definitive agreement to acquire TruBridge, a NASDAQ-listed provider of healthcare technology solutions for rural and community hospitals.
The proposed acquisition is aimed at expanding IKS Health’s capabilities in delivering technology-driven healthcare solutions, particularly in underserved rural and community healthcare systems across the United States.
The company said the deal will combine its care enablement platform with TruBridge’s expertise in revenue cycle management and electronic health record (EHR) solutions. This integration is expected to enhance access to quality healthcare, improve clinical outcomes, and strengthen operational efficiency for hospitals and clinicians.
Post-acquisition, the combined entity will focus on delivering connected workflows and continuous improvements across healthcare delivery. The platform is also expected to integrate artificial intelligence with human expertise to address complex operational challenges and improve efficiency across the care continuum.
IKS Health noted that the combined organisation will support more than 2,000 healthcare institutions and over 150,000 clinicians, offering a broad portfolio of AI-driven and human-led solutions aimed at improving clinical, operational, and financial outcomes.
Commenting on the development, Sachin K. Gupta, Founder and Global CEO of IKS Health, said the acquisition aligns with the company’s long-term vision of building a comprehensive care ecosystem. He added that integrating TruBridge’s systems with IKS Health’s AI-driven capabilities will help move beyond traditional healthcare processes to solving deeper operational challenges.
TruBridge President and CEO Chris Fowler said the partnership will expand the company’s focus on strengthening rural and community healthcare while enhancing patient outcomes and operational capabilities.
Under the terms of the agreement, TruBridge shareholders will receive $26.25 in cash per share. The transaction has been approved by the boards of both companies and is expected to close in the third quarter of calendar year 2026, subject to customary approvals and conditions.
The acquisition will be financed primarily through new debt, including a term loan, as disclosed by the company.